Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 90,068 More Arrow 103,259 Less Arrow 24,634
Financial expenses 70,875 Less Arrow 32,502 Less Arrow 886
Earnings before taxes -558,035 More Arrow -407,608 More Arrow -398,563
EBITDA -523,013 More Arrow -393,314 Less Arrow -397,725
Total assets 683,792 More Arrow 1,127,581 Less Arrow 736,444
Current assets 574,383 More Arrow 1,072,317 Less Arrow 685,206
Current liabilities 215,599 Less Arrow 176,891 Less Arrow 124,499
Equity capital -112,758 More Arrow 402,885 More Arrow 550,855
- share capital 36,965 Less Arrow 36,776 Less Arrow 33,692
Employees (average) 159 Less Arrow 144 Less Arrow 116

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency -16.5% More Arrow 35.7% More Arrow 74.8%
Turnover per employee 566 More Arrow 717 Less Arrow 212
Profit as a percentage of turnover -619.6% More Arrow -394.7% Less Arrow -1617.9%
Return on assets (ROA) -71.2% More Arrow -33.3% Less Arrow -54.0%
Current ratio 266.4% More Arrow 606.2% Less Arrow 550.4%
Return on equity (ROE) 494.9% Less Arrow -101.2% More Arrow -72.4%
Change turnover -13,723 More Arrow 80,620 Less Arrow 20,200
Change turnover % -13% More Arrow 356% More Arrow 456%
Chg. No. of employees 15 More Arrow 28 More Arrow 34
Chg. No. of employees % 10% More Arrow 24% More Arrow 41%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.